For persons interested in all phases of the litigation industry, Max Minzer contines to write a series of informative and thought...

Corporate Counsel includes an interesting July 8, 2014 review of SCOTUS’ “business law” decisions by a small group of lawyers focused on...

Even after much progress since 1968, a bone marrow transplant remains a barbaric procedure in which the immune system is more or less...

Slater & Gordon was the first law firm in the world to become a public company, and evolved from an Australian plaintiff’s firm into a...

The TortsProfBlog brings news that the Pennsylvania Supreme Court will decide if “bad faith” claims are assignable. More specifics are...

In the age of email, tweets and more, e-discovery and its volume create issues and expense that did not exist in the days of paper. So,...

Another court has imposed limits on the scope of releases and a chapter 11 order purporting to broadly cover future claims. The new...

The yin and yang of litigation creates interesting alternatoives. Today, we hear some on the defense side complain bitterly that...

Pharma lawyers also have concerns about insurers creating conflicts of interest by mismanaging underlying pharma case that involve...

P.F. Changs is the latest target for class action based on allegations regarding failed cybersecurity.  LegalNewsline has the story in a...

Today, through the leadership of Mary Hesdorffer and others, the Mesothelioma Applied Research Foundation is about mesothelioma science,...

The Conglomerate blog brings forward yet another interesting topic, paper and author in a July 7, 2014 post. The topic is “For-Profit...

Nathan Schactman’s  July 6,  2014 post offers interesting comments on the rules for expert causation testimony. Not too many will take...

The molecular biology revolution continues, thanks to massive amounts of data and computer power. Building from the Human Genome Project...

Low dose CT scans are part of the future in the US for persons with increased risks for lung disease, and will play a role in claiming to...

Mistakes can be costly. GM is moving forward to deal with its ignition switch issue, and the costs are estimated at $3 billion or more....

Subrogation claims and liens of various kinds continue to assert a growing influence on mass tort litigation. In a new example, Blue...

It may be the corporate boards are starting to get the message about the need to pay attention to science, technology and cybersecurity....

Most insurers, defendants and various interested others can and should be spending money to find additional causes of mesothelioma. The...

A new opinion came out last Friday from the 1st District appellate court in Chicago, and further lowers the  worker’s comp bar in...